• LAST PRICE
    15.7400
  • TODAY'S CHANGE (%)
    Trending Up0.4000 (2.6076%)
  • Bid / Lots
    14.2000/ 1
  • Ask / Lots
    15.8500/ 20
  • Open / Previous Close
    15.1600 / 15.3400
  • Day Range
    Low 15.0400
    High 15.8600
  • 52 Week Range
    Low 10.4800
    High 21.6800
  • Volume
    212,979
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 15.34
TimeVolumeKDNY
09:32 ET599515.43
09:33 ET10015.34
09:37 ET46015.37
09:39 ET10015.44
09:44 ET10015.57
09:48 ET20015.55
09:50 ET70015.54
09:51 ET10015.62
09:53 ET20015.425
09:55 ET23115.57
09:57 ET30015.69
10:00 ET70015.69
10:02 ET231215.6
10:06 ET10015.61
10:08 ET10015.595
10:09 ET154315.65
10:11 ET10015.66
10:13 ET161515.67
10:15 ET30015.74
10:18 ET10015.72
10:20 ET180015.51
10:22 ET10015.5
10:24 ET70015.37
10:27 ET20015.375
10:29 ET45115.52
10:31 ET30015.64
10:33 ET60015.41
10:40 ET40015.43
10:42 ET50015.47
10:44 ET124515.4
10:45 ET60015.4
10:47 ET110015.4625
10:51 ET140115.41
10:54 ET33915.55
10:56 ET20015.47
10:58 ET30015.595
11:00 ET30015.72
11:02 ET80015.66
11:03 ET40015.69
11:05 ET10015.79
11:07 ET30015.79
11:09 ET20015.795
11:12 ET20015.81
11:14 ET60015.68
11:16 ET10015.77
11:18 ET10015.85
11:20 ET30015.79
11:25 ET55915.79
11:30 ET80015.82
11:32 ET75015.75
11:34 ET10015.715
11:36 ET30015.675
11:39 ET83915.74
11:41 ET20015.86
11:43 ET10015.795
11:45 ET60015.71
11:48 ET30015.64
11:50 ET55715.69
11:52 ET50015.68
11:56 ET20015.73
11:57 ET10015.65
11:59 ET50015.65
12:01 ET30015.58
12:03 ET20015.625
12:06 ET10015.54
12:08 ET40015.56
12:10 ET86915.5627
12:14 ET30015.61
12:19 ET10015.53
12:21 ET20015.53
12:24 ET10015.53
12:26 ET20015.53
12:28 ET20015.51
12:30 ET10015.47
12:32 ET10015.47
12:35 ET10015.47
12:37 ET20015.46
12:42 ET20015.49
12:44 ET60615.51
12:46 ET10015.5
12:48 ET20015.5
12:50 ET20015.53
12:51 ET10015.48
12:53 ET110115.47
12:57 ET10015.43
01:02 ET50015.43
01:04 ET10015.4
01:06 ET10015.37
01:08 ET30015.36
01:11 ET50015.39
01:13 ET136715.42
01:15 ET30015.44
01:18 ET40015.435
01:20 ET10015.435
01:24 ET30015.42
01:31 ET90015.36
01:33 ET70415.4
01:40 ET20015.4
01:42 ET20015.49
01:47 ET50015.38
01:51 ET69915.47
01:54 ET56015.56
02:00 ET10015.6
02:02 ET50015.57
02:03 ET100015.59
02:09 ET30015.6
02:12 ET30015.58
02:14 ET49015.58
02:16 ET70315.6
02:18 ET50015.65
02:21 ET10015.58
02:23 ET136715.66
02:27 ET100015.61
02:30 ET43715.69
02:34 ET30015.67
02:36 ET10015.75
02:38 ET140015.71
02:39 ET21115.75
02:41 ET20015.7
02:43 ET10015.73
02:45 ET10015.64
02:48 ET20915.61
02:50 ET30015.68
02:52 ET20015.6
02:54 ET201015.56
02:56 ET30015.52
02:57 ET124515.59
02:59 ET10015.69
03:01 ET83615.72
03:03 ET20015.75
03:06 ET10015.76
03:08 ET158515.8
03:10 ET10015.82
03:12 ET50015.75
03:14 ET20015.7
03:15 ET20015.73
03:17 ET20015.69
03:19 ET43715.76
03:21 ET20015.69
03:24 ET62615.8
03:26 ET159415.79
03:28 ET40015.73
03:30 ET160015.79
03:32 ET40015.79
03:33 ET20015.78
03:35 ET283815.665
03:37 ET63115.68
03:39 ET20015.61
03:42 ET328615.67
03:44 ET149915.78
03:46 ET150015.75
03:48 ET137715.7
03:50 ET74915.7
03:51 ET410915.79
03:53 ET50015.84
03:55 ET293415.8
03:57 ET648715.76
04:00 ET7172415.74
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKDNY
Chinook Therapeutics Inc
811.5M
-2.5x
---
United StatesOMGA
Omega Therapeutics Inc
811.7M
0.0x
---
United StatesTNYA
Tenaya Therapeutics Inc
811.2M
-12.1x
---
United StatesGLUE
Monte Rosa Therapeutics Inc
809.7M
-11.0x
---
United StatesVBIV
VBI Vaccines Inc
802.8M
-10.3x
---
United StatesBCAB
Bioatla Inc
803.0M
-8.7x
---
As of 2021-12-02

Company Information

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing precision medicines for kidney diseases. The Company's development programs consist of Atrasentan, BION-1301 and CHK-336. Atrasentan is a potent and selective endothelin A receptor antagonist that are developed for the treatment of proteinuric glomerular diseases. BION-1301 is an investigational humanized IgG4 monoclonal antibody that blocks APRIL binding to both the B-cell maturation antigen (BCMA), and transmembrane activator and CAML interactor (TACI), receptors, as a disease-modifying therapy for Immunoglobulin A Nephropathy (IgAN). CHK-336 is a liver-targeted oral small molecule lactate dehydrogenase (LDHA), inhibitor, which are developed for the treatment of primary hyperoxaluria.

Contact Information

Headquarters
400 Fairview Avenue North, Suite 900SEATTLE, WA, United States 98109
Phone
206-485-7051
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Eric Dobmeier
Chief Financial Officer
Eric Bjerkholt
Chief Operating Officer
Tom Frohlich
Chief Scientific Officer
Andrew King
Chief Medical Officer
Alan Glicklich

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$811.5M
Revenue (TTM)
$-22.1M
Shares Outstanding
52.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.16
EPS
$-6.35
Book Value
$7.91
P/E Ratio
-2.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.